Literature DB >> 9875047

A population study of chromosome 22q11 deletions in infancy.

J Goodship1, I Cross, J LiLing, C Wren.   

Abstract

AIMS: To determine the prevalence of submicroscopic deletions within chromosome band 22q11 in infants with significant heart disease and compare this with the prevalence of other chromosomal abnormalities causing significant heart disease. To determine a minimum prevalence of deletions within chromosome band 22q11 in infants in the general population.
METHODS: Chromosome analysis was performed on samples from infants born in the former UK Northern Health Region in 1994 and 1995 who either had significant heart disease or who were suspected to have a chromosome band 22q11 deletion following referral to the Northern Genetics Service. Significant heart disease was defined as major structural malformation or cases where invasive investigation or intervention was required in infancy.
RESULTS: Chromosome band 22q11 deletions were identified in nine infants in a population of 69,129 livebirths, giving a minimum prevalence of 13 per 100,000 (95% confidence interval 4.5 to 21.5). Six cases had significant heart disease, one of whom died before diagnosis. In the same population there were 53 cases of trisomy 21, 15 of whom had significant heart disease.
CONCLUSION: The most common chromosomal cause of significant congenital heart disease remains trisomy 21, while the second most common chromosomal cause is deletion in chromosome band 22q11.

Entities:  

Mesh:

Year:  1998        PMID: 9875047      PMCID: PMC1717723          DOI: 10.1136/adc.79.4.348

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  18 in total

1.  Renal and urological tract malformations caused by a 22q11 deletion.

Authors:  K Devriendt; A Swillen; J P Fryns; W Proesmans; M Gewillig
Journal:  J Med Genet       Date:  1996-04       Impact factor: 6.318

2.  Prevalence of 22q11 microdeletion.

Authors:  S Tézenas Du Montcel; H Mendizabai; S Aymé; A Lévy; N Philip
Journal:  J Med Genet       Date:  1996-08       Impact factor: 6.318

3.  Isomerism of the atrial appendages associated with 22q11 deletion in a fetus.

Authors:  R W Yates; F L Raymond; A Cook; G K Sharland
Journal:  Heart       Date:  1996-12       Impact factor: 5.994

4.  Microdeletion 22q11 in complex cardiovascular malformations.

Authors:  Y Mehraein; C F Wippermann; I Michel-Behnke; T K Nhan Ngo; U Hillig; M Giersberg; U Aulepp; H Barth; B Fritz; H Rehder
Journal:  Hum Genet       Date:  1997-04       Impact factor: 4.132

5.  Importance of microdeletions of chromosomal region 22q11 as a cause of selected malformations of the ventricular outflow tracts and aortic arch: a three-year prospective study.

Authors:  S A Webber; E Hatchwell; J C Barber; P E Daubeney; J A Crolla; A P Salmon; B R Keeton; I K Temple; N R Dennis
Journal:  J Pediatr       Date:  1996-07       Impact factor: 4.406

6.  22q11 deletions in isolated and syndromic patients with tetralogy of Fallot.

Authors:  F Amati; A Mari; M C Digilio; R Mingarelli; B Marino; A Giannotti; G Novelli; B Dallapiccola
Journal:  Hum Genet       Date:  1995-05       Impact factor: 4.132

7.  Confirmation that the velo-cardio-facial syndrome is associated with haplo-insufficiency of genes at chromosome 22q11.

Authors:  D Kelly; R Goldberg; D Wilson; E Lindsay; A Carey; J Goodship; J Burn; I Cross; R J Shprintzen; P J Scambler
Journal:  Am J Med Genet       Date:  1993-02-01

8.  Frequency of a 22q11 deletion in patients with conotruncal cardiac malformations: a prospective study.

Authors:  K Takahashi; S Kido; K Hoshino; K Ogawa; H Ohashi; Y Fukushima
Journal:  Eur J Pediatr       Date:  1995-11       Impact factor: 3.183

9.  Presentation of obstructive left heart malformations in infancy.

Authors:  M Abu-Harb; J Wyllie; E Hey; S Richmond; C Wren
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1994-11       Impact factor: 5.747

10.  Death in infancy from unrecognised congenital heart disease.

Authors:  M Abu-Harb; E Hey; C Wren
Journal:  Arch Dis Child       Date:  1994-07       Impact factor: 3.791

View more
  89 in total

1.  Clinically detectable copy number variations in a Canadian catchment population of schizophrenia.

Authors:  Anne S Bassett; Gregory Costain; Wai Lun Alan Fung; Kathryn J Russell; Laura Pierce; Ronak Kapadia; Ronald F Carter; Eva W C Chow; Pamela J Forsythe
Journal:  J Psychiatr Res       Date:  2010-11       Impact factor: 4.791

Review 2.  CHD associated with syndromic diagnoses: peri-operative risk factors and early outcomes.

Authors:  Benjamin J Landis; David S Cooper; Robert B Hinton
Journal:  Cardiol Young       Date:  2015-09-08       Impact factor: 1.093

3.  MLPA: a rapid, reliable, and sensitive method for detection and analysis of abnormalities of 22q.

Authors:  J A S Vorstman; G R Jalali; E F Rappaport; A M Hacker; C Scott; B S Emanuel
Journal:  Hum Mutat       Date:  2006-08       Impact factor: 4.878

4.  Prevalence of 22q11.2 deletions in 311 Dutch patients with schizophrenia.

Authors:  Mechteld L C Hoogendoorn; Jacob A S Vorstman; Gholam R Jalali; Jean-Paul Selten; Richard J Sinke; Beverly S Emanuel; René S Kahn
Journal:  Schizophr Res       Date:  2007-10-26       Impact factor: 4.939

5.  Premature death in adults with 22q11.2 deletion syndrome.

Authors:  A S Bassett; E W C Chow; J Husted; K A Hodgkinson; E Oechslin; L Harris; C Silversides
Journal:  J Med Genet       Date:  2009-02-25       Impact factor: 6.318

6.  Secondary immunologic consequences in chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome).

Authors:  R Zemble; E Luning Prak; K McDonald; D McDonald-McGinn; E Zackai; K Sullivan
Journal:  Clin Immunol       Date:  2010-05-15       Impact factor: 3.969

7.  Clinical features of 78 adults with 22q11 Deletion Syndrome.

Authors:  Anne S Bassett; Eva W C Chow; Janice Husted; Rosanna Weksberg; Oana Caluseriu; Gary D Webb; Michael A Gatzoulis
Journal:  Am J Med Genet A       Date:  2005-11-01       Impact factor: 2.802

8.  Congenital anomalies and rhabdoid tumor associated with 22q11 germline deletion and somatic inactivation of the SMARCB1 tumor suppressor.

Authors:  George Toth; Claudia B Zraly; Tricia L Thomson; Carolyn Jones; Shawn Lapetino; Jonathan Muraskas; Jiwang Zhang; Andrew K Dingwall
Journal:  Genes Chromosomes Cancer       Date:  2011-03-15       Impact factor: 5.006

9.  The Neuroanatomy of Autism Spectrum Disorder Symptomatology in 22q11.2 Deletion Syndrome.

Authors:  M Gudbrandsen; E Daly; C M Murphy; R H Wichers; V Stoencheva; E Perry; D Andrews; C E Blackmore; M Rogdaki; L Kushan; C E Bearden; D G M Murphy; M C Craig; C Ecker
Journal:  Cereb Cortex       Date:  2019-07-22       Impact factor: 5.357

10.  Communication of Psychiatric Risk in 22q11.2 Deletion Syndrome: A Pilot Project.

Authors:  Sarah J Hart; Kelly Schoch; Vandana Shashi; Nancy Callanan
Journal:  J Genet Couns       Date:  2015-11-18       Impact factor: 2.537

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.